During the past decade, Haematologische Schwerpunktpraxis conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haematologische Schwerpunktpraxis" #1 sponsor was "German CLL Study Group" with 5 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Heidelberg University" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "MedSIR" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haematologische Schwerpunktpraxis" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Haematologische Schwerpunktpraxis" are "Chronic Lymphocytic Leukemia" (5 trials), "Leukemia" (2 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Haematologische Schwerpunktpraxis" in a lesser frequency.

Most popular intervention types in "Haematologische Schwerpunktpraxis" are "Drug" (11 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (4 trials), "Cyclophosphamide" (2 trials), "Rituximab" (2 trials), "Carboplatin" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Haematologische Schwerpunktpraxis" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Haematologische Schwerpunktpraxis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Haematologische Schwerpunktpraxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haematologische Schwerpunktpraxis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".